Personal information

Activities

Employment (1)

Cardiff University: Cardiff, GB

2023-07-01 to present | Research Associate in Bioinformatics (DPMCN)
Employment
Source: Self-asserted source
Christopher Wills

Works (5)

Germline variation in RASAL2 may predict survival in patients with RAS‐activated colorectal cancer

Genes, Chromosomes and Cancer
2023-06 | Journal article
Contributors: Christopher Wills; Katie Watts; Timothy S. Maughan; David Fisher; Nada A. Al‐Tassan; Richard S. Houlston; Valentina Escott‐Price; Jeremy P. Cheadle
Source: check_circle
Crossref

Relationship between 233 colorectal cancer risk loci and survival in 1926 patients with advanced disease

BJC Reports
2023-06-22 | Journal article
Part of ISSN: 2731-9377
Contributors: Christopher Wills; Amy Houseman; Katie Watts; Timothy S. Maughan; David Fisher; Richard S. Houlston; Hannah D. West; Valentina Escott-Price; Jeremy Cheadle
Source: Self-asserted source
Christopher Wills

Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndrome.

International journal of cancer
2022-04-25 | Journal article
Source: Self-asserted source
Christopher Wills

A genome-wide search for determinants of survival in 1926 patients with advanced colorectal cancer with follow-up in over 22,000 patients

European Journal of Cancer
2021-12 | Journal article
Contributors: Christopher Wills; Yazhou He; Matthew G. Summers; Yi Lin; Amanda I. Phipps; Katie Watts; Philip J. Law; Nada A. Al-Tassan; Timothy S. Maughan; Richard Kaplan et al.
Source: check_circle
Crossref

Genome‐wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancer

International Journal of Cancer
2021-07 | Journal article
Part of ISSN: 0020-7136
Part of ISSN: 1097-0215
Source: Self-asserted source
Christopher Wills